ENvue Medical, Inc.

FEED Healthcare Medical Devices

ENvue Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 51.6%, EPS grew 75.8%, free cash flow grew 19.8% and total debt fell 45.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.37 0.12 −24.49%
Market cap
$950.0K
P/E
0.0×
Fwd P/E
−1.3×
Dividend yield
—
F-score
2/9
Altman Z
−4.72
Beneish M
6.64
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

2 2 3 2
ROE
(20.67%) (98.32%) (110.87%) (138.10%)
ROA
(15.52%) (74.97%) (89.37%) (109.44%)
ROIC
(16.16%) (47.18%) (50.17%) (53.44%)
Return on Tangible Assets
304.52% (2,297.95%) 6,936.04% 2,100.26%
Average Days of Receivables
34.26 41.32 55.56 38.85
Free Cash Flow per Share
(101.83) (180.34) (45.30) (22.90)
Free Cash Flow
(7.28) (9.43) (12.41) (11.74)
Other line items

Show all line items

Columns are period end dates